Actively Recruiting
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Led by Seung-Jung Park · Updated on 2025-06-13
50000
Participants Needed
1
Research Sites
1143 weeks
Total Duration
On this page
Sponsors
S
Seung-Jung Park
Lead Sponsor
C
CardioVascular Research Foundation, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
CONDITIONS
Official Title
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of coronary disease suitable for percutaneous coronary intervention (PCI)
- No clinical or lesion limitations for treatment
- Age 19 years or older
You will not qualify if you...
- Use of multiple types of drug-eluting stents in the same patient
- Terminal illness with life expectancy less than 1 year
- Presence of cardiogenic shock
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Korean centres
Multiple Locations, South Korea
Actively Recruiting
Research Team
S
Seung-Jung Park, MD
CONTACT
D
Duk-Woo Park, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
27
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here